Lyon, France

Yvette Quentin


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Lyon, FR (1992)
  • Lyons, FR (1993)

Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yvette Quentin: Innovator in Anti-Allergic Drug Development

Introduction

Yvette Quentin is a notable inventor based in Lyon, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-allergic drugs. With a total of 2 patents, her work has the potential to impact the medical community positively.

Latest Patents

Yvette Quentin's latest patents focus on 4(3H)-pteridinone compounds. The first patent describes these compounds represented by a specific formula, where X can be an oxygen or sulfur atom, and Y can be a hydrogen atom or a lower alkyl radical, particularly a methyl radical at the 6-position or a hydroxyl group at the 7-position. The compounds have applications as anti-allergic drugs. The second patent also relates to 4(3H)-pteridinones, detailing their preparation processes and the drugs containing them, emphasizing their use in treating allergies.

Career Highlights

Throughout her career, Yvette has worked with several reputable companies, including Lipha and Lyonnaise Industrielle Pharmaceutique. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Yvette has collaborated with notable coworkers such as Gerard Ferrand and Herve Dumas. These partnerships have likely enriched her research and development efforts.

Conclusion

Yvette Quentin stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of anti-allergic drug development. Her patents and collaborations reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…